134 related articles for article (PubMed ID: 16133385)
21. The potential clinical value of FDG-PET for recurrent renal cell carcinoma.
Nakatani K; Nakamoto Y; Saga T; Higashi T; Togashi K
Eur J Radiol; 2011 Jul; 79(1):29-35. PubMed ID: 20015602
[TBL] [Abstract][Full Text] [Related]
22. Partial adrenalectomy for renal cell carcinoma with bilateral adrenal metastases.
Schomer NS; Mohler JL
J Urol; 1995 Apr; 153(4):1196-8. PubMed ID: 7869497
[TBL] [Abstract][Full Text] [Related]
23. [Late solitary metastasis of a renal cancer to the contralateral adrenal gland].
Mignon F; Mesurolle B; Sissakian JF; Bruckert F; Guichoux F; Barré O; Chagnon S; Lacombe P
J Radiol; 1999 Sep; 80(9):939-42. PubMed ID: 11048548
[TBL] [Abstract][Full Text] [Related]
24. Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Mennitto A; Grassi P; Verzoni E; Ratta R; Procopio G
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):250-251. PubMed ID: 28070961
[No Abstract] [Full Text] [Related]
25. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.
Kang DE; White RL; Zuger JH; Sasser HC; Teigland CM
J Urol; 2004 May; 171(5):1806-9. PubMed ID: 15076281
[TBL] [Abstract][Full Text] [Related]
26. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
27. CT with anatomic delineation identifying renal cell carcinoma with normal metabolic activity on F-18 FDG PET imaging.
Cherng SC; Chang CY; Fan YM; Chen CY; Chiu CS; Cheng CY
Clin Nucl Med; 2006 Aug; 31(8):490-1. PubMed ID: 16855441
[No Abstract] [Full Text] [Related]
28. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH
Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368
[TBL] [Abstract][Full Text] [Related]
29. FDG PET/CT in detection of adrenal metastasis in patients with renal cell carcinoma.
Kumar R; Shamim SA; Shandal V; Sharma P; Gadodia A; Malhotra A
Clin Nucl Med; 2011 Jul; 36(7):513-7. PubMed ID: 21637050
[TBL] [Abstract][Full Text] [Related]
30. An original case of isolated unilateral adrenal metastasis from penile carcinoma: documentation by 18F-FDG-PET imaging and histopathology.
Joshi P; Joshi-Kulkarni M; Basu S; Desmukh M; Asopa R; Kane S
Hell J Nucl Med; 2010; 13(1):63-4. PubMed ID: 20411175
[No Abstract] [Full Text] [Related]
31. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
[TBL] [Abstract][Full Text] [Related]
32. (99m)Tc-DTPA uptake in clear-cell renal carcinoma metastases.
Antunovic L; Franklin-Bezerra B; Rodari M; Pepe G; Chiti A
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):169-70. PubMed ID: 22811984
[No Abstract] [Full Text] [Related]
33. Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
Mankoff DA; Thompson JA; Gold P; Eary JF; Guinee DG; Samlowski WE
AJR Am J Roentgenol; 1997 Oct; 169(4):1049-50. PubMed ID: 9308463
[No Abstract] [Full Text] [Related]
34. Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer.
Mizuno T; Kamai T; Abe H; Sakamoto S; Kitajima K; Nishihara D; Yuki H; Kambara T; Betsunoh H; Yashi M; Fukabori Y; Kaji Y; Yoshida K
BMC Cancer; 2015; 15():1097. PubMed ID: 25784113
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma.
Ozturk H
Minerva Urol Nefrol; 2016 Jun; 68(3):263-9. PubMed ID: 25916217
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
37. A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET.
Basely M; Bonnel S; Maszelin P; Verdalle P; Bussy E; de Jaureguiberry JP
Clin Nucl Med; 2009 Sep; 34(9):566-9. PubMed ID: 19692815
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Lawrentschuk N; Davis ID; Bolton DM; Scott AM
BJU Int; 2006 May; 97(5):916-22. PubMed ID: 16643471
[No Abstract] [Full Text] [Related]
40. FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography.
Sizemore AW; Jacobs MP; Mantil JC; Hahm GK
Clin Nucl Med; 2007 Apr; 32(4):309-11. PubMed ID: 17413583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
